Skip to main content

Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF

Large cap biotechnology companies are flush with cash, and they’re on the prowl for takeover targets, a scenario that could bode well for the ALPS Medical Breakthroughs ETF (SBIO). SBIO focuses on small- and mid-cap companies that have one or more drugs in either Phase II or Phase III trials....
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.